VT
IBB icon

Vise Technologies’s iShares Biotechnology ETF IBB Stock Holding History

Vise Technologies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$609K Buy
3,202
+187
+6% +$32.1K 0.01% 1041
2026
Q1 		$509K Hold
3,015
– – 0.01% 858
2025
Q4 		$509K Buy
+3,015
New +$490K 0.01% 863
2025
Q3 		– Sell
-2,754
Closed -$348K – 1206
2025
Q2 		$348K Buy
+2,754
New +$338K 0.01% 785
2024
Q4 		$339K Buy
2,568
+223
+10% +$31.4K 0.03% 549
2024
Q3 		$341K Sell
2,345
-170
-7% -$24.6K 0.04% 408
2024
Q2 		$345K Sell
2,515
-1,763
-41% -$235K 0.06% 288
2024
Q1 		$587K Buy
+4,278
New +$584K 0.12% 180

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Vise Technologies's IBB Position: Q2 2026 in Review

Vise Technologies increased its iShares Biotechnology ETF (IBB) stake by 6.2% in Q2 2026, buying an estimated $32.1K and bringing the position to 3,202 shares worth $609K. The position accounts for 0.01% of the portfolio, ranked #1041.

Vise Technologies first reported a position in IBB in Q1 2024 and has held it in 8 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Vise Technologies held 3,202 shares of iShares Biotechnology ETF worth $609K as of Q2 2026.
  • Vise Technologies bought 187 iShares Biotechnology ETF shares in Q2 2026, an estimated $32.1K.
  • iShares Biotechnology ETF made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1041 holding.
  • Vise Technologies first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 8 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.